Quetiapine as monotherapy for social anxiety disorder: A placebo-controlled study

@article{Vaishnavi2007QuetiapineAM,
  title={Quetiapine as monotherapy for social anxiety disorder: A placebo-controlled study},
  author={Sandeep Vaishnavi and Syed Alamy and Wei Zhang and Kathryn M. Connor and Jonathan Robert Davidson},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  year={2007},
  volume={31},
  pages={1464-1469}
}
Social anxiety disorder (SAD) is one of the most common anxiety disorders. Reports have suggested an effect of the atypical antipsychotic quetiapine in anxiety disorders. Given these considerations, we conducted a controlled trial of quetiapine monotherapy in SAD. Fifteen patients were randomized to quetiapine (up to 400 mg/day) or placebo for 8 weeks. The Brief Social Phobia Scale (BSPS) and the Clinical Global Impression of Improvement Scale (CGI-I) were the primary outcome measures, while… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 19 CITATIONS, ESTIMATED 36% COVERAGE

52 Citations

01020'10'13'16'19
Citations per Year
Semantic Scholar estimates that this publication has 52 citations based on the available data.

See our FAQ for additional information.

Similar Papers

Loading similar papers…